Apollo Hospitals Enterprise Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.
Published 25 Aug 2026 | Healthcare Services | Market Cap: ₹1.2L Cr
Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
From Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹8,878
Market Cap
₹1.2L Cr
P/E Ratio
59.4
How does Apollo Hospitals Enterprise Ltd rank in Healthcare Services?
Compare Apollo Hospitals Enterprise Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹6.6K Cr, net profit ₹551 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth.
- →30% growth currently driven by top 5 markets; expansion planned into new markets.
- →Pharmacy business acquiring 200,000-220,000 new customers monthly, expected to increase with 7,500 outlets synergy.
- →Diagnostics business growing 25%-30%, with plans to further grow and strengthen through integration.
- →Hospital services targeting mid-teen revenue growth in FY27; expecting gradual revenue acceleration and better asset utilization.
- →New hospitals adding about 1,400 beds, with phased commissioning; 500-600 beds expected operational by mid-FY27.
- →Apollo 24/7 digital platform expected to break even soon, driving margin improvement in integrated business.
- →Focus on sustainable, calibrated growth with improving unit economics across segments.
See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.
🏗️ Capital Expenditure Plans
Yes- →Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
- →INR 1,980 crore capex is planned for FY27 to commission 1,000 new beds.
- →Four new hospitals operationalized in FY26 with 855 beds capacity; 185 beds operationalized, remaining 670 beds to be commissioned over next 12 months.
- →Two more hospitals (Sarjapur and Gurugram) expected to be commissioned in the next two quarters, adding up to approximately 1,400 beds in metro markets by FY28.
- →Investments ongoing in clinical leadership (oncology, robotics, advanced care), technology, and digital health to improve consumer engagement and operational integration.
- →Apollo HealthCo continuing investment in digital tech and insurance with quarterly ESOP costs around INR 50 crore expected to taper.
- →Combined efforts focus on sustainable long-term growth, integrating the Apollo ecosystem across physical and digital platforms.
See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.
📋 Order Book & Pipeline
No informationKey Metrics
1 of 5 growth signals positive in the Q4 FY26 call.
Revenue
Margin
Capex
Fundraise
Order Book
How does Apollo Hospitals Enterprise Ltd rank vs peers in Healthcare Services?
Pro featureSee full Healthcare Services sector rankings
Continue your research
What Apollo Hospitals Enterprise Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Health X Platform Ltd (Q4 FY26)
Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…
- PARKHOSPS (Q4 FY26)
Total planned capex for the next two years is around INR 500 crores. Key concall takeaways from Park Medi World's Q4 FY26 earnings call — and how it ranks…
- Vimta Labs Ltd (Q4 FY26)
. Key concall takeaways from Vimta Labs Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Vijaya Diagnostic Centre Ltd (Q4 FY26)
Hyderabad to sustain double-digit growth (~20%) in near term, with additional spokes opening and market share gains. Key concall takeaways from Vijaya…
Frequently Asked Questions
What were Apollo Hospitals Enterprise Ltd Q4 FY26 results?
Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
What is Apollo Hospitals Enterprise Ltd share price analysis?
Apollo Hospitals Enterprise Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 59.4 with a market cap of ₹124,992 Cr. Investors should review the full earnings analysis for detailed insights.
Is Apollo Hospitals Enterprise Ltd planning capital expenditure?
Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.